(a) The Fatality and Mortality Review Team shall establish the following advisory panels to carry out the purposes of this article, including:
(1) An unintentional pharmaceutical drug overdose fatality review panel to examine, analyze, and review deaths resulting from unintentional prescription or pharmaceutical drug overdose;